Key facts
- Notable investors include First Capital Investment Management Co., Shenzhen Yuanshan Private Equity Investment Management.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Guoke Xingan
- ·The full record, as it builds
Funding rounds
No funding rounds for Guoke Xingan are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Guoke Xingan
Manufacturer of a high-end molecular diagnostic instrument and reagents intended to advance precision testing in healthcare. The company offers integrated instrumentation, dedicated reagents and automated workflows, enabling clinical laboratories and diagnostic service providers to deliver more reliable, rapid and scalable molecular diagnostics.
- Sector
- Healthcare
- HQ
- Suzhou, China
- Founded
- 2016
- Website
- casens.cn/
- Ownership
- Privately Held (backing)
Guoke Xingan doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Guoke Xingan shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Guoke Xingan in its N-PORT filings yet. We sweep new filings monthly.